Innate Immune Regulation by HSF1 in Liver Inflammatory Injury

HSF1 在肝脏炎症损伤中的先天免疫调节

• 批准号: 10078934
• 负责人: Bibo Ke
• 金额: $ 39万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-01-25 至 2023-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10078934
• 关键词: Adaptor Signaling Protein; Address; Antioxidants; Binding; Binding Proteins; Cell division; Cellular Stress; Clinical; Clinical Research; Complement Factor B; Data; Disease; Excision; Factor X; Failure; Functional disorder; Future; Goals; HSF1; Hemorrhagic Shock; Hepatic; Immune; In Vitro; Inflammasome; Inflammation; Inflammatory; Inflammatory Response; Injury; Innate Immune Response; Innate Immune System; Knock-out; Kupffer Cells; Link; Liver; MAP3K7 gene; MAP3K7IP1 gene; MAPK8 gene; Mediating; Mediator of activation protein; Mitotic; Molecular; Mus; Myelogenous; Natural Immunity; Necrosis; Organ Transplantation; Oxidative Stress; Pathogenesis; Pathway interactions; Phosphotransferases; Production; Protein-Serine-Threonine Kinases; Reactive Oxygen Species; Regulation; Reperfusion Injury; Role; Scaffolding Protein; Scheme; Signal Transduction; Signaling Molecule; Sterility; Stress; System; TLR4 gene; TRAF6 gene; TXNIP gene; Testing; Therapeutic; Tissues; Transcriptional Activation; Transforming Growth Factors; Transplant Recipients; base; beta catenin; immunoregulation; in vivo; liver inflammation; liver injury; liver ischemia; liver transplantation; novel; novel therapeutic intervention; prevent; response; translational study

PROJECT SUMMARY Liver ischemia and reperfusion injury (IRI), an innate immunity-dominant local sterile inflammatory response, is a major cause for hepatic dysfunction and failure following liver transplantation, resection, and hemorrhagic shock. Oxidative stress has been recognized as an important factor in the pathogenesis of hepatic IRI, in which IR activates liver macrophages (Kupffer cells) to generate reactive oxygen species (ROS), leading to sterile inflammation in the liver. ROS is an endogenous `danger' signal and can be released from necrotic or stressed cells to trigger NLRP3 inflammasome activation. Recent study revealed that activation of the NLRP3 inflammasome required ROS-dependent NEK7, a serine-threonine kinase involved in mitotic cell division. NEK7 directly binds to NLRP3 and promotes inflammatory response, suggesting that NEK7 is an essential mediator to trigger innate immunity during inflammatory response. It has been shown that activation of antioxidant defense system prevents ROS-induced liver damage whereas disruption of NLRP3 adaptor protein ASC reduces inflammatory response in liver IRI. Moreover, mice with myeloid-specific HSF1 knockout (HSF1M- KO) enhanced NLRP3 functions and exacerbated IR-induced liver damage through activation of transcription factor X-box-binding protein (XBP1). Ultimately, HSF1 activation increased β-catenin activity leading to reduced ROS production and NLRP3 activation. Although these results point towards the HSF1-β-catenin axis as a novel master-switch of innate immunity in liver inflammatory injury, it remains unknown how HSF1 modulates NEK7 function leading to reduced NLRP3 activation in response to IR-induced stress. The TLR4/TRAF6 axis mediates the NOX2-dependent production of ROS, which is crucial for the activation of TXNIP. TLR signaling can interact with transforming growth factor β-activated kinase 1 (TAK1) to initiate inflammatory cascade whereas activation of NEK7 promotes NLRP3 inflammasome pathway. Thus, TXNIP and TAK1 are likely to be essential for the HSF1-mediated regulation of NEK7 functions during liver inflammatory injury. The overall goal of this proposal is to dissect the functions and molecular mechanisms of HSF1-dependent regulation of NEK7 function in IR-stressed livers. The hypothesis is that HSF1 regulates NEK7-mediated innate immune responses in hepatic IRI by: 1) controlling TAK1 activity; and 2) inhibiting TXNIP activation. To test this hypothesis, the following specific aims are proposed: i) dissect mechanisms by which HSF1 controls the TAK1-NEK7 interaction in IR-stressed liver; and ii) determine mechanisms by which HSF1 regulates the TXNIP-NEK7 axis in IR-stressed liver. These studies will increase the understanding of the hepatic regulatory network of innate immunity in IR-induced liver inflammation. These findings will also have far reaching implications for therapeutic modulation of ischemic tissue damage in organ transplantation and other sterile inflammatory disease states.

项目总结